Pain

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC30-7

DiraChart Clinical Reference
Protected section 7 of 26
← Document menu
Home Care · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 7 of 26PreviousNext

5. Abnormal findings

Abnormal findings and what they may signal — each warrants Mode B focused documentation and, where parameters are met, intervention and notification:

  • Pain above the patient's goal, or new pain or a change in pattern, location, or quality.
  • Neuropathic features (burning, shooting, electric) suggesting nerve involvement.
  • Functional decline attributable to pain — reduced ambulation, impaired activities of daily living, disrupted sleep, or low mood.
  • Analgesic adverse effects — constipation, nausea, sedation, or signs of respiratory depression with opioids.
  • Signs of under-treatment (persistent pain limiting function) or over-treatment (excess sedation, slowed respirations).
  • Pain accompanied by red-flag features — new severe pain, neurologic deficit, or signs of an acute process.
Section NavigationPart 7 of 26PreviousNext